Primecap Management CO Arbutus Biopharma Corp Transaction History

Primecap Management CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.24 - $3.06 $39,872 - $54,468	-17,800 Reduced 5.15%	328,100 $754,000
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $12,488 - $17,360	-5,600 Reduced 1.59%	345,900 $1.05 Million
Q4 2022 Feb 13, 2023	SELL	$1.91 - $2.85 $137,138 - $204,630	-71,800 Reduced 16.96%	351,500 $818,000
Q2 2022 Aug 11, 2022	SELL	$1.98 - $3.17 $74,646 - $119,509	-37,700 Reduced 8.18%	423,300 $1.15 Million
Q1 2022 May 11, 2022	SELL	$2.42 - $3.98 $21,780 - $35,820	-9,000 Reduced 1.91%	461,000 $1.37 Million
Q4 2021 Feb 11, 2022	SELL	$3.11 - $4.61 $93,300 - $138,300	-30,000 Reduced 6.0%	470,000 $1.83 Million
Q2 2020 Aug 13, 2020	SELL	$0.91 - $2.36 $72,891 - $189,036	-80,100 Reduced 13.81%	500,000 $910,000
Q1 2020 May 14, 2020	SELL	$1.01 - $3.42 $20,099 - $68,058	-19,900 Reduced 3.32%	580,100 $586,000
Q4 2019 Feb 14, 2020	SELL	$0.87 - $2.89 $2.99 Million - $9.94 Million	-3,440,900 Reduced 85.15%	600,000 $1.67 Million
Q4 2018 Feb 12, 2019	SELL	$3.5 - $9.66 $103,250 - $284,970	-29,500 Reduced 0.72%	4,040,900 $15.5 Million
Q3 2018 Nov 13, 2018	BUY	$7.85 - $12.35 $549,500 - $864,500	70,000 Added 1.75%	4,070,400 $38.5 Million
Q4 2017 Feb 13, 2018	BUY	$4.45 - $7.7 $44,500 - $77,000	10,000 Added 0.25%	4,000,400 $20.2 Million
Q3 2017 Nov 13, 2017	BUY	$3.4 - $7.0 $13.6 Million - $27.9 Million	3,990,400	3,990,400 $24.7 Million

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

Stay updated on Primecap Management CO with notifications on news.